A 2003 mouse study specifically on Epitalon reported that treatment did not influence mean lifespan in female Swiss-derived SHR mice, though there were effects on chromosomal aberrations, estrous function, and spontaneous tumor incidence
It usually takes care of the problem
P., Joshi, S., Purty, A
Others may reduce dose, change frequency, consider microdosing when appropriate, or transition off medication with closer follow-up
For many patients, the decision to start GLP-1 therapy involves weighing upfront costs against potential metabolic benefits and long-term health outcomes
Patients with type 2 diabetes and elevated inflammatory markers, particularly those with established cardiovascular disease or high cardiovascular risk, represent a group where GLP-1 receptor agonists are already recommended by the ADA and American College of Physicians (ACP)